Events

We are thrilled to announce that Karen Damian will be representing Symeres at Biofit 2024 in Lille!

As one of Europe’s leading Biotech partnering events, Biofit offers a fantastic opportunity to forge new connections and explore cutting-edge technologies. Whether you are from academia, a small biotech, or a big pharmaceutical company, we would love to meet and discuss how our expertise can support your goals.

We look forward to seeing you in Lille and exploring opportunities to collaborate!

Symeres is thrilled to announce Sascha Hartmann will be at Genesis 2024, the premier networking and deal-making conference for the global life sciences community. Genesis brings together key players from biotech, pharma, and investment sectors to explore the latest innovations and collaborations in healthcare and life sciences.

As a leading Contract Research Organization (CRO), Symeres specializes in advancing drug discovery and development. We offer end-to-end solutions, from medicinal chemistry and ADME-Tox services to cutting-edge process R&D and GMP manufacturing, helping biotech and pharma partners achieve their goals efficiently and effectively.

We look forward to discussing your needs and exploring exciting opportunities for collaboration.

Our Directors of Business Development, Sascha Hartmann and Roger McDonald, will be attending the upcoming Recent Trends in Medicinal Chemistry and Enabling Technologies conference hosted by the Society for Medicines Research and the Biological and Medicinal Chemistry Sector of the Royal Society of Chemistry. This 1-day event will dive into the latest developments in medicinal chemistry, chemistry-based drug discovery enabling technologies, and chemical biology. The meeting will showcase the innovative work happening across the UK in advancing drug discovery targets, technologies, and lead series in support of medicines research.

We’re happy to announce that André de Vries, Director of Innovation and Business Development, and Kirill Kulish, Business Development Scientist, will join the 20th Dutch Life Sciences Conference.

With over 3,000 Life Sciences & Health R&D companies, 13 universities, and 2,100+ ongoing clinical trials, the Dutch life sciences sector continues to drive innovation in biotech sector. This annual event will bring together entrepreneurs and industry experts to exchange ideas on the latest trends and emerging technologies.

André and Kirill are looking forward to engaging with peers, discovering potential collaborations, and exploring new ways to support life sciences innovation.

Reach out if you’d like to connect at the conference!